ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269757 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269757; 2) Community: the network communities that were significantly associated with the response to NSC 269757; 3) Molecule: the relationships between components within communities and NSC 269757; 4) MDR: the compounds that were significantly associated with the NSC 269757.

NSC Compound Enrichment Correlation
NSC 88054 Null 0.0462077035966081 0.38778542
NSC 22348 1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- 0.0462077035966084 0.2690126
NSC 308847 Amonafide 0.0462077035966088 -0.027875978
NSC 635544 Null 0.0462077035966088 0.26802698
NSC 678914 4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]- 1-methoxy-, dihydrochloride 0.0462077035966088 0.054068557
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.0462077035966088 0.21140906
NSC 758664 Sirolimus [USAN] 0.0462077035966088 -0.016900319
NSC 94600 Camptothecin 0.0462077035966088 -0.028396924
NSC 106246 Null 0.0480633950058471 0.34253417
NSC 143241 Dibenzo[de,g]quinoline-6-carboxylic acid, 4,5-dihydro- 1,2,9,10-tetramethoxy-, ethyl ester 0.0480633950058471 0.32458277
Total:74  Current:71    [First] [Prev] [Next] [Last]